Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Aug 31, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.9M
Net Open-Market Flow
-$4.9M
Transactions
13
12 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 28, 2026Option exercise(M)10K$135.42$1.3M334K
Aug 28, 2026Sell(S)480$514.26$247K333K
Aug 28, 2026Sell(S)2K$515.46$840K332K
Aug 28, 2026Sell(S)2K$516.16$1.2M329K
Aug 28, 2026Sell(S)1K$517.11$768K328K
Aug 28, 2026Sell(S)1K$518.14$697K327K
Aug 28, 2026Sell(S)412$519.19$214K326K
Aug 28, 2026Sell(S)751$520.30$391K325K
Aug 28, 2026Sell(S)286$521.58$149K325K
Aug 28, 2026Sell(S)517$522.40$270K325K
Aug 28, 2026Sell(S)6$523.42$3K325K
Aug 28, 2026Sell(S)200$524.42$105K324K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 28, 2026Option exercise(M)10K$037K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000131) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.